The vote was 89-3 on the motion to end debate on the Food and Drug Administration Safety and Innovation ACt (S. 3187).

A week earlier the House approved the bill and sent the amended version back to the Senate.

The legislation reauthorizes certain FDA programs and expands a user-fee program in order to speed up the FDA's approval process for certain drug and medical device applications.

Sens. Richard BurrRichard BurrWhen education is an ignored national security matter Five takeaways from a busy day of Russia hearings Rubio: 'All options should be on table' if Flynn refuses new subpoenas MORE (R-N.C.), Rand PaulRand PaulPaul: 0B Saudi arms deal ‘a travesty’ Senate feels pressure for summer healthcare vote Overnight Defense: Trump budget gets thumbs down from hawks | UK raises threat level after Manchester attack | Paul to force vote on 0B Saudi arms deal MORE (R-Ky.) and Bernie SandersBernie SandersOvernight Healthcare: CBO fallout | GOP senators distance themselves from House bill | Trump budget chief blasts score | Schumer says House bill belongs 'in the trash' Schumer: Republicans should throw their health bill 'in the trash' Overnight Finance: GOP bill would leave 23M more uninsured, says CBO | Trump aides defend budget | Mnuchin asks for clean debt hike before August | Ryan says House could pass bill without border tax MORE (I-Vt.) voted against the motion to end debate.